{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-005923","form_type":"8-K","ticker":"ANIK","cik":"0000898437","company_name":"Anika Therapeutics, Inc.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.326843+00:00","generated_at":"2026-05-30T07:53:06.208367+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Anika Q3 rev $38.8M (-7% YoY), net loss $29.9M; restructures, sells Arthrosurface, plans Parcus divestiture","bullets":["Revenue $38.8M (-7% YoY), net loss $29.9M ($2.03/sh); adj net loss $3.8M ($0.25/sh).","Integrity Implant System grew 40%+ sequentially, >500 surgeries since launch, Regenerative Solutions up 17%.","Exiting Arthrosurface (sold) and Parcus Medical (divestiture planned) to focus on HA technology and Commercial Channel.","Updated 2024 guidance: Commercial Channel +14% to +19%, OEM -8% to -10%, Adj EBITDA $16-18M; restructuring charges $3-5M cash, $27-29M non-cash.","First Hyalofast PMA module filed Oct 28; Cingal NDA path progress including acquisition of Aristospan NDA."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-005923","json":"https://secwatch.observer/filing/0001171843-24-005923.json","markdown":"https://secwatch.observer/filing/0001171843-24-005923.md","text":"https://secwatch.observer/filing/0001171843-24-005923.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/898437/000117184324005923/0001171843-24-005923-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/898437/000117184324005923/f8k_103124.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:53:06.208367+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}